A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo
- 15 April 1999
- journal article
- Published by Elsevier BV in Bone
- Vol. 24 (5), 437-449
- https://doi.org/10.1016/s8756-3282(99)00020-4
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Substrate Recognition by Osteoclast Precursors Induces C-src/Microtubule AssociationThe Journal of cell biology, 1997
- Focal Adhesion Kinase Tyrosine-861 Is a Major Site of Phosphorylation by SrcBiochemical and Biophysical Research Communications, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor: STUDY OF Lck- AND FynT-DEPENDENT T CELL ACTIVATIONJournal of Biological Chemistry, 1996
- Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Impaired Long-Term Potentiation, Spatial Learning, and Hippocampal Development in fyn Mutant MiceScience, 1992
- Osteoclasts express high levels of pp60c-src in association with intracellular membranes.The Journal of cell biology, 1992
- Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.JCI Insight, 1992
- Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitectureBone, 1992
- N-terminal truncation of salmon calcitonin leads to calcitonin antagonists: Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivoBiochemical and Biophysical Research Communications, 1992
- Increased trabecular bone mass in rats treated with human synthetic parathyroid hormoneMetabolic Bone Disease and Related Research, 1984